Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1999
10/12/1999US5965121 Compounds and compositions for delivering active agents
10/12/1999US5965119 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
10/12/1999US5965118 Polymer-platinum compounds
10/12/1999US5965116 Use of acrylic copolymers in cosmetics and compositions used
10/12/1999US5965106 In vivo binding pair pretargeting
10/12/1999CA2168732C Gelatin capsules containing a highly concentrated acetaminophen solution
10/12/1999CA2112423C Non-reducing saccharide-forming enzyme, and its preparation and uses
10/12/1999CA2027864C Formulations for sustained release dressings and their use
10/10/1999CA2273546A1 Nefazodone dosage form
10/07/1999WO1999050398A2 Recombinant anti-tumor rnase
10/07/1999WO1999050303A2 Immune response modulator alpha-2 macroglobulin complex
10/07/1999WO1999049908A1 Temperature controlled solute delivery system
10/07/1999WO1999049901A1 Water soluble paclitaxel derivatives
10/07/1999WO1999049897A1 Hemoglobin-polysaccharide conjugates
10/07/1999WO1999049896A1 A drug composition containing sodium pravastatin
10/07/1999WO1999049895A2 Method for increasing the permeability of horny human tissue
10/07/1999WO1999049892A2 Use of active p40 conjugates for nasal delivery
10/07/1999WO1999049887A1 Use of protease inhibitors for treating skin wounds
10/07/1999WO1999049868A1 Sustained-release composition containing cefaclor
10/07/1999WO1999049863A1 Sustained release preparations
10/07/1999WO1999049861A1 Deodorant agents for oral use for discharges and method for relieving odor of discharges
10/07/1999WO1999049857A1 Stable dosage forms of fluoxetine and its enantiomers
10/07/1999WO1999049853A1 Therapeutic system which can be moisture-activated
10/07/1999WO1999049848A1 Anticancer compositions
10/07/1999WO1999049846A2 Compositions containing microparticles of water-insoluble substances and method for their preparation
10/07/1999WO1999049845A1 Peroral active agent suspension
10/07/1999WO1999049844A2 Method for producing transdermal therapeutic systems by using basic alkali metal salts for converting active agent salts into free bases
10/07/1999WO1999049843A1 Solid, quick dissolving cetirizine formulations
10/07/1999WO1999049842A1 Fizzy formulations
10/07/1999WO1999049835A1 An acidified composition for topical treatment of nail and skin conditions
10/07/1999WO1999049832A1 Agents promoting laminin production in skin cells
10/07/1999WO1999024077A3 Compositions and methods for targeted delivery of biologically-active factors
10/07/1999WO1999015147A3 Use of alkylmonoglucosides as molecular vectors
10/07/1999DE19910856A1 Strukturiertes Wasser für eine verbesserte Anfeuchtung Structured water for improved wetting
10/07/1999DE19815127A1 Mittel mit Copolymerisaten aus N-Vinylcarbonsäureamiden und Monomeren mit hydrophobem Rest, und Verwendung dieser Copolymerisate Means with copolymers of N-vinylcarboxamides and monomers with hydrophobic residue, and use of these copolymers
10/07/1999DE19814814A1 Aqueous or water-soluble composition containing iminophenazine derivative useful for preparing antimycobacterial, immunosuppressant, antiinflammatory and/or antiviral medicaments
10/07/1999DE19814739A1 Solubilizing agents useful in pharmaceutical, cosmetic and food compositions
10/07/1999DE19814730A1 Pharmaceutical and cosmetic compositions with matrix containing N-vinyllactam or N-vinylamine based copolymer
10/07/1999DE19814257A1 Brauseformulierungen Effervescent formulations
10/07/1999DE19814256A1 Feste, schnellzerfallende Cetirizin-Formulierungen Solid rapidly disintegrating cetirizine formulations
10/07/1999DE19812777A1 Verfahren zur beschleunigten Aufnahme vom Carotinoiden in Serum und Gewebe A method for accelerated uptake of carotenoids in serum and tissue
10/07/1999CA2731416A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999CA2326774A1 An acidified composition for topical treatment of nail and skin conditions
10/07/1999CA2326603A1 A drug composition containing sodium pravastatin
10/07/1999CA2326438A1 Use of protease inhibitors for treating skin wounds
10/07/1999CA2325858A1 Stable dosage forms of fluoxetine and its enantiomers
10/07/1999CA2324864A1 Immune response modulator alpha-2 macroglobulin complex
10/07/1999CA2324646A1 Recombinant anti-tumor rnase
10/07/1999CA2324477A1 Use of active p40 conjugates for nasal delivery
10/06/1999EP0947584A1 Loxoprofen-containing preparation for external use
10/06/1999EP0947491A1 Highly pure squalane, raw material for pharmaceuticals and cosmetics prepared by using the same and method for producing the same
10/06/1999EP0947244A1 Solubilizers, emulsifiers and dispersants
10/06/1999EP0947243A2 Agent containing copolymers of n-vinyl carboxylic acid amides and monomers with hydrophobic moiety and their use
10/06/1999EP0947202A2 Alginate-bioactive agent conjugates
10/06/1999EP0947201A1 Pharmaceutical composition of hedgehog proteins and use thereof
10/06/1999EP0947200A2 Compositions comprising Cetrorelix acetate for the treatment of female infertility and gonadal protection
10/06/1999EP0947193A2 Percutaneously applicable preparation and suppository containing an antidementia medicament
10/06/1999EP0946744A1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes
10/06/1999EP0946718A1 Nucleic acid constructs and uses thereof for direct nucleic acid incorporation into cells
10/06/1999EP0946637A1 Polymer film compositions for capsules
10/06/1999EP0946624A1 Biodegradable targetable microparticle delivery system
10/06/1999EP0946621A1 Cationic film-forming polymer compositions containing same, and uses thereof, including topical delivery system and method of delivering agents to the skin and hair
10/06/1999EP0946217A1 Process for preparing polymer coatings grafted with polyethylene oxide chains containing covalently bonded bio-active agents
10/06/1999EP0946205A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them
10/06/1999EP0946202A2 Contrast agents
10/06/1999EP0946198A2 Stabilized conjugates of uncomplexed subunits of multimeric proteins
10/06/1999EP0946197A1 Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients
10/06/1999EP0946193A1 Stabilizers for lyophilized vaccines
10/06/1999EP0946159A1 An oil composition of dihydropolyprenols
10/06/1999EP0946156A2 Therapeutic agents
10/06/1999EP0946154A1 Liquisolid systems and methods of preparing same
10/06/1999EP0946150A1 Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium
10/06/1999EP0946147A1 Treatment of equine laminitis
10/06/1999EP0946146A2 New aqueous medicament preparations for the production of propellent gas-free aerosols
10/06/1999EP0946145A2 Antitussive drugs delivered by ion exchange resins
10/06/1999EP0946143A2 A nitroimidazole gel composition
10/06/1999EP0722473A4 Metallospheres and superclusters
10/06/1999EP0527942B1 Colonic drug delivery system
10/06/1999CN1230890A Injectable formulations of avermectins and milbemycins
10/06/1999CN1230437A Process for producing solid dosage forms
10/06/1999CN1230402A Production of composite preparation of bone morphogenesis protein and collagen particle
10/06/1999CN1045392C Internal guide therapeutic medicine for rheumatoid disease and making method
10/06/1999CN1045391C Oral delivery system
10/05/1999US5962668 Nucleic acids encoding antiviral proteins and peptides fused to effector proteins
10/05/1999US5962653 Methods of obtaining antiviral proteins and antiviral peptides from Nostoc ellipsosporum
10/05/1999US5962626 Surfactants
10/05/1999US5962620 Hydrophicic and hydrophobic polyether polyurethanes and uses therefor
10/05/1999US5962536 Injectable propofol formulations
10/05/1999US5962526 Pharmaceutical compositions containing hydroxycarboxylic acids and/or ketocarboxylic acids and methods of using same
10/05/1999US5962522 Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
10/05/1999US5962520 Drug delivery
10/05/1999US5962512 Oil containing 5-methoxypsoralen at a concentration of 60-100 ppm, and its use in treatment of psoriasis
10/05/1999US5962488 Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
10/05/1999US5962461 Mixture of polyvinylpyrrolidone, polyol and ammonium glycyrrhizinate
10/05/1999US5962442 Administering a 3-oxo-4-azasteroid
10/05/1999US5962433 Topical composition containing hyaluronic acid and NSAIDS
10/05/1999US5962432 Sterilized, isotonic and pH-adjusted pharmaceutical formulation of uridine triphosphate
10/05/1999US5962427 Targeting, transferring dna into mammalian repair cells
10/05/1999US5962424 Inducing selectin expression using ionizing radiation
10/05/1999US5962423 Neutralization of shiga-like toxins
1 ... 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 ... 1712